ATE276741T1 - Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung - Google Patents

Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung

Info

Publication number
ATE276741T1
ATE276741T1 AT00990848T AT00990848T ATE276741T1 AT E276741 T1 ATE276741 T1 AT E276741T1 AT 00990848 T AT00990848 T AT 00990848T AT 00990848 T AT00990848 T AT 00990848T AT E276741 T1 ATE276741 T1 AT E276741T1
Authority
AT
Austria
Prior art keywords
galenic
production
compositions containing
medicinal compositions
preconcentrate
Prior art date
Application number
AT00990848T
Other languages
English (en)
Inventor
Josiane Lemut
Pascale Blouquin
Philippe Reginault
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Application granted granted Critical
Publication of ATE276741T1 publication Critical patent/ATE276741T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00990848T 1999-12-31 2000-12-29 Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung ATE276741T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9916807A FR2803203B1 (fr) 1999-12-31 1999-12-31 Nouvelles formulations galeniques du fenofibrate
PCT/FR2000/003738 WO2001049262A1 (fr) 1999-12-31 2000-12-29 Formulations galeniques du fenofibrate et leur procede d'obtention

Publications (1)

Publication Number Publication Date
ATE276741T1 true ATE276741T1 (de) 2004-10-15

Family

ID=9554113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00990848T ATE276741T1 (de) 1999-12-31 2000-12-29 Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung

Country Status (8)

Country Link
US (1) US20030082215A1 (de)
EP (1) EP1242047B1 (de)
AT (1) ATE276741T1 (de)
AU (1) AU3030801A (de)
DE (1) DE60014162T2 (de)
ES (1) ES2226976T3 (de)
FR (1) FR2803203B1 (de)
WO (1) WO2001049262A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US6982281B1 (en) * 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
US20040005339A1 (en) * 2002-06-28 2004-01-08 Shojaei Amir H. Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
AU2003285932A1 (en) * 2002-10-23 2004-05-13 Glaxosmithkline Biologicals S.A. Methods for vaccinating against malaria
JP2006511525A (ja) 2002-12-13 2006-04-06 ヤゴテック アーゲー ナノ粒子状スピロノラクトン局所製剤
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
US9259390B2 (en) * 2003-08-13 2016-02-16 The University Of Houston System Parenteral and oral formulations of benzimidazoles
US20050096390A1 (en) * 2003-10-10 2005-05-05 Per Holm Compositions comprising fenofibrate and pravastatin
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
MXPA06003813A (es) * 2003-10-10 2006-06-14 Lifecycle Pharma As Forma solida de dosificacion que comprende un fibrato y una estatina.
CN1874758A (zh) * 2003-10-10 2006-12-06 生命周期药物公司 包含贝特和史达汀的固体剂型
CA2540984C (en) 2003-10-10 2011-02-08 Lifecycle Pharma A/S A solid dosage form comprising a fibrate
US8026281B2 (en) * 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate
CA2589654C (en) * 2004-12-06 2016-02-16 Reliant Pharmaceuticals, Inc. Omega-3 fatty acids and dyslipidemic agent for lipid therapy
EP1830804A2 (de) * 2004-12-06 2007-09-12 Reliant Pharmaceuticals, Inc. Stabile zusammensetzungen von fenofibrat mit fettsäureestern
KR20070108945A (ko) * 2005-03-08 2007-11-13 릴라이언트 파마슈티컬스 인코퍼레이티드 스타틴과 오메가-3 지방산 및 그 조합물을 이용한 치료
JP5230416B2 (ja) 2005-07-29 2013-07-10 テイボテク・フアーマシユーチカルズ Ｃ型肝炎ウイルスの大員環状阻害剤
ES2373685T3 (es) 2005-07-29 2012-02-07 Tibotec Pharmaceuticals Inhibidores macrocíclicos del virus de la hepatitis c.
JP2013047282A (ja) * 2006-08-31 2013-03-07 Aska Pharmaceutical Co Ltd フェノフィブラート含有組成物
JP5186159B2 (ja) * 2006-08-31 2013-04-17 あすか製薬株式会社 フェノフィブラート含有組成物
WO2008055146A2 (en) * 2006-10-31 2008-05-08 Wyeth Formulations of phospholipase enzyme inhibitors
WO2010082214A2 (en) * 2008-07-03 2010-07-22 Panacea Biotec Limited Fenofibrate formulation with enhanced oral bioavailability
CN101711738B (zh) * 2008-10-08 2012-09-05 中国人民解放军军事医学科学院毒物药物研究所 非诺贝特的口服药物组合物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20120213855A1 (en) * 2011-02-17 2012-08-23 Cima Labs Inc. Dosage forms for weakly ionizable compounds
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
EP3432729B1 (de) * 2016-03-25 2025-08-13 Adisseo France S.A.S. Nanokapseln mit einem fettlöslichen wirkstoff, herstellung und verwendungen
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease
EP3952900A1 (de) * 2019-04-11 2022-02-16 R.P. Scherer Technologies, LLC Formulierung zur oralen verabreichung von proteinen, peptiden und kleinen molekülen mit schlechter permeabilität
JP2024512417A (ja) * 2021-03-12 2024-03-19 ニコベンチャーズ トレーディング リミテッド 自己乳化系を含む経口製品
CN118304260A (zh) * 2023-10-24 2024-07-09 浙江大学长三角智慧绿洲创新中心 一种非诺贝特油性制剂、口服药物和制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
FR2730231B1 (fr) * 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
FR2737121B1 (fr) * 1995-07-27 1997-10-03 Cl Pharma Nouvelles formulations galeniques du fenofibrate et leurs applications
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
BE1011363A3 (fr) * 1997-09-11 1999-08-03 Smb Technology Capsules semi-solides autoemulsionnables matricielles a action prolongee.
WO1999029300A1 (en) * 1997-12-10 1999-06-17 Rtp Pharma Inc. Self-emulsifying fenofibrate formulations

Also Published As

Publication number Publication date
ES2226976T3 (es) 2005-04-01
FR2803203A1 (fr) 2001-07-06
AU3030801A (en) 2001-07-16
FR2803203B1 (fr) 2002-05-10
EP1242047B1 (de) 2004-09-22
DE60014162T2 (de) 2005-09-22
EP1242047A1 (de) 2002-09-25
WO2001049262A1 (fr) 2001-07-12
US20030082215A1 (en) 2003-05-01
DE60014162D1 (de) 2004-10-28

Similar Documents

Publication Publication Date Title
ATE276741T1 (de) Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung
EP0790822B1 (de) MITTEL MIT GESTEUERTER FREISETZUNG, DIE EINE UMGEKEHRTE MICELLARE (L2) STRUKTUR ODER EINE NORMALE MICELLARE (l1) STRUKTUR BILDEN
EP1109532B1 (de) Oralzusammensetzung als mikroemulsion von silybin
CA2294033C (en) Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
ES2101574T3 (es) Composicion administrable por via oral apta para formar una microemulsion.
JP2002509877A5 (de)
NO20002991L (no) Farmasøytiske sammensetninger som inneholder en <omega>-3- fettsyreolje
JP2005225897A (ja) サイクロスポリンａを含む無油医薬組成物
RU2001119167A (ru) Самоэмульгирующиеся композиции для плохорастворимых в воде лекарственных препаратов
HU218279B (en) Pharmaceutical composition containing cyclosporin-d-derivative and process for producing them
CA2424596C (en) Oral self-emulsifying formulations of pyranone protease inhibitors
AU2005206084A1 (en) Microemulsions for pharmaceutical compositions
ATE322250T1 (de) Selbstemulgierendes system zur arzneistoffabgabe von fettlöslichen wirkstoffen
JPS615011A (ja) 安定なビタミンｅの可溶化液
JP2006509785A (ja) ビフェニルジメチルジカルボン酸の経口用マイクロエマルション組成物
WO1999043299A3 (en) Oral formulation for hydrophilic drugs
KR100449818B1 (ko) 가용화 기법인 ｓｍｅｄｄｓ를 이용한 이부프로펜의연질캅셀제 및 주사제
KR100524700B1 (ko) 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물
KR100580577B1 (ko) 자가 미세 유화형 약물 전달 시스템을 이용하는 소염 진통활성을 갖는 약제 조성물
JP2003261442A (ja) 塩酸プソイドエフェドリンを含む軟カプセル剤
CO4480099A1 (es) Un preconcentrado de microemulsion que comprende un agente activo dificilmente soluble y un medio portador
KR20010011249A (ko) 페노피브레이트를 함유하는 경구용 마이크로에멀젼 조성물
WO2008142090A1 (en) Self-emulsifying formulation of tipranavir for oral administration
TH30907A (th) ส่วนประกอบทางเภสัชกรรมที่มีไซโคสพอริน
JPH04360824A (ja) 薬物含有脂肪乳剤

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1242047

Country of ref document: EP